MGC Pharmaceuticals: Funding, Investors & Team (Sep 2026)
MGC Pharmaceuticals Ltd., a publicly listed Australian company (ASX:MXC), was established in 2015 by influential executives from the Israeli medical cannabis industry. The company aimed to utilize their intellectual property, expertise, and connections to create a successful global CBD and medical cannabis business, specifically targeting the European and Australian CBD markets. MGC operates on a global scale, focusing on enhancing the entire product chain, including cultivating and breeding unique strains and developing effective medicine delivery systems. Given the rapid growth of the medical cannabis industry, especially in the CBD sector, it is now crucial to make smart decisions in choosing partnerships and associations.
MGC Pharmaceuticals has raised $850k across 1 funding round on record, the most recent an undisclosed round of $850k announced in Jul 2023.
That round is below the $2.3M median round size for Community and Lifestyle companies tracked on FundedIQ over the last two years.
MGC Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jul 2023.
MGC Pharmaceuticals Funding Rounds
MGC Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
MGC Pharmaceuticals Funding Compared to Other Community and Lifestyle Startups
MGC Pharmaceuticals' latest round of $850k is below the median round in Community and Lifestyle. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MGC Pharmaceuticals in Community and Lifestyle and Perth
Companies Similar to MGC Pharmaceuticals
Coast 4C supports sustainable seaweed supply, combining community, commerce, conservation, and climate…
Future Minds Network (FMN) is an Australian social enterprise empowering Generation Z youth with…
Aura Holdings develops and manages luxury retirement living communities in Brisbane. They provide several…
At Argent BioPharma, we are committed to pioneering the future of healthcare. Our approach is rooted in a…
Bare specializes in offering top-notch cremation services at a competitive price in order to allow families…
Maslow is a fintech company that examines money through the lens of the broader community.
White Box Enterprises aims to generate employment opportunities for 5,000 marginalized Australians by 2030…
Earlywork offers a fast and fair way to start a career in tech sales in Australia and Singapore. Their…
IDEA is a specialized institution catering to young individuals with innovative, entrepreneurial, and…
Kali Healthcare is a group consisting of obstetricians and engineers who are committed to transforming the…
MGC Pharmaceuticals Funding FAQs
What does MGC Pharmaceuticals do?
MGC Pharmaceuticals Ltd., a publicly listed Australian company (ASX:MXC), was established in 2015 by influential executives from the Israeli medical cannabis industry. The company aimed to utilize their intellectual property, expertise, and connections to create a successful global CBD and medical cannabis business, specifically targeting the European and Australian CBD markets. MGC operates on a global scale, focusing on enhancing the entire product chain, including cultivating and breeding unique strains and developing effective medicine delivery systems. Given the rapid growth of the medical cannabis industry, especially in the CBD sector, it is now crucial to make smart decisions in choosing partnerships and associations.
How much funding has MGC Pharmaceuticals raised?
MGC Pharmaceuticals has raised $850k across 1 round on record. The most recent is an undisclosed round of $850k announced in Jul 2023.
When did MGC Pharmaceuticals last raise funding?
MGC Pharmaceuticals' most recent funding round on record is an undisclosed round of $850k, announced in Jul 2023.
Who founded MGC Pharmaceuticals?
FundedIQ lists Nativ Segev (Founder) at MGC Pharmaceuticals.
Where is MGC Pharmaceuticals headquartered?
MGC Pharmaceuticals is based in Perth, Western Australia, Australia.
How many employees does MGC Pharmaceuticals have?
MGC Pharmaceuticals is in the 11-50 employee band.
How does MGC Pharmaceuticals' funding compare to other Community and Lifestyle startups?
MGC Pharmaceuticals' latest round of $850k is below the $2.3M median round size for Community and Lifestyle companies on FundedIQ across 1,484 tracked companies over the last two years.
About FundedIQ's MGC Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MGC Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.